Open a bounty challenge Fund this gap and accept submissions. SPEC-033.
Composite
Novelty
Mechanistic
Druggability
Priority
86%
Importance
89%
Tractability
82%
Market price
50%

Description

The abstract notes that APOE pathogenesis has expanded beyond amyloid-β to include tau pathology, but the specific mechanisms linking APOE to tau neurofibrillary degeneration remain unexplained. Understanding this connection is crucial for developing targeted therapies.

Gap type: unexplained_observation Source paper: APOE and Alzheimer’s disease: advances in genetics, pathophysiology, and therapeutic approaches. (2021, Lancet Neurol, PMID:33340485)

Resolution criteria

[“APOE4 expression in P301S tau mice (APOE4xP301S) vs P301S alone shows >=50% increase in hippocampal tau tangle load with preserved amyloid status”, “APOE4-specific astrocyte-neuron co-culture shows non-amyloid-dependent increase in neuronal tau phosphorylation via secreted lipoproteins”, “APOE4/4 iPSC-derived neurons show elevated p-tau217 and p-tau396 vs APOE3/3 at matched A\u03b2 levels”, “CRISPR correction of APOE4 to APOE3 in APOE4/4 neurons reduces tau phosphorylation to APOE3/3 levels”]

Evidence summary

{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:16.868872+00:00”, “resolution_summary”: “Resolved by hypothesis h-44195347: APOE4 Allosteric Rescue via Small Molecule Chaperones. Supporting evidence includes debate sess_SDA-2026-04-13-gap-pubmed-20260410-170325-196c7ee5_20260413-235122.”, “match_counts”: {“hypothesis_matches”: 2, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-44195347”, “title”: “APOE4 Allosteric Rescue via Small Molecule Chaperones”, “score”: 0.226, “reason”: “23 token overlaps; entity overlap: apoe”, “analysis_id”: “sda-2026-04-01-gap-010”, “target_gene”: “APOE”, “target_pathway”: “Apolipoprotein E lipid transport”, “disease”: “neurodegeneration”, “composite_score”: 0.764904, “confidence_score”: 0.4, “status”: “debated”, “pubmed_evidence_ids”: [“27097127”, “27365453”, “30335591”, “31367008”, “33891876”]}, {“id”: “h-0bcda2e0”, “title”: “CLU/APOE Duality in Amyloid Clearance Determines Cell-Type-Specific Vulnerability Thresholds”, “score”: 0.225, “reason”: “19 token overlaps; entity overlap: apoe”, “analysis_id”: “SDA-2026-04-15-gap-debate-20260410-112607-0a3749ea”, “target_gene”: “APOE, CLU”, “target_pathway”: “APOE-mediated cholesterol/lipid transport”, “disease”: “neurodegeneration”, “composite_score”: 0.811, “confidence_score”: 0.78, “status”: “promoted”, “pubmed_evidence_ids”: [“23296339”, “31564456”, “36348357”, “41422555”, “41606232”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-170325-196c7ee5_20260413-235122”, “title”: “The study shows that MCT1 disruption leads to axon degeneration and neuron death, but the specific molecular pathways linking lactate transport dysfunction to neuronal damage remain unexplained. Understanding this mechanism is critical for developing targeted neuroprotective therapies.\n\nGap type: unexplained_observation\nSource paper: Oligodendroglia metabolically support axons and contribute to neurodegeneration. (2012, Nature, PMID:22801498)”, “score”: 0.559, “reason”: “16 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-170325-196c7ee5”, “quality_score”: 0.82, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-170325-196c7ee5_20260414-001952”, “title”: “The study shows that MCT1 disruption leads to axon degeneration and neuron death, but the specific molecular pathways linking lactate transport dysfunction to neuronal damage remain unexplained. Understanding this mechanism is critical for developing targeted neuroprotective therapies.\n\nGap type: unexplained_observation\nSource paper: Oligodendroglia metabolically support axons and contribute to neurodegeneration. (2012, Nature, PMID:22801498)”, “score”: 0.559, “reason”: “16 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-170325-196c7ee5”, “quality_score”: 0.78, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062207-e4ce5cf0_task_9aae8fc5”, “title”: “The abstract mentions that pathological seeds have different characteristics and conformations, but the underlying molecular mechanisms that generate this diversity remain unclear. Understanding these mechanisms is critical for developing targeted therapeutic interventions.\n\nGap type: unexplained_observation\nSource paper: Protein transmission in neurodegenerative disease. (2020, Nat Rev Neurol, PMID:32203399)”, “score”: 0.549, “reason”: “14 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062207-e4ce5cf0”, “quality_score”: 0.65, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c_task_9aae8fc5”, “title”: “The abstract identifies that neurons show resistance to autophagy induction, but the mechanistic basis remains incompletely defined. Understanding this resistance is crucial for developing neuron-targeted autophagy therapies for ALS.\n\nGap type: unexplained_observation\nSource paper: Autophagy and ALS: mechanistic insights and therapeutic implications. (2022, Autophagy, PMID:34057020)”, “score”: 0.519, “reason”: “13 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c”, “quality_score”: 0.65, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-08-gap-pubmed-20260406-062111-e3e328bf_task_9aae8fc5”, “title”: “The abstract mentions that antibody discovery has improved understanding of myelitis pathophysiology but focuses on a review of uncommon myelopathies where mechanisms remain poorly characterized. Understanding these mechanisms is critical for developing targeted therapies for rare but debilitating conditions.\n\nGap type: unexplained_observation\nSource paper: Uncommon inflammatory/immune-related myelopathies. (2021, J Neuroimmunol, PMID:34715593)”, “score”: 0.493, “reason”: “13 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-08-gap-pubmed-20260406-062111-e3e328bf”, “quality_score”: 0.655, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}